Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1963 1
1964 1
1966 1
1967 3
1968 3
1969 1
1970 5
1971 1
1972 3
1973 3
1975 3
1977 5
1978 5
1979 6
1980 8
1981 4
1982 6
1983 7
1984 4
1985 5
1986 5
1987 6
1988 7
1989 6
1990 11
1991 6
1992 12
1993 8
1994 8
1995 10
1996 18
1997 19
1998 11
1999 8
2000 8
2001 5
2002 9
2004 4
2005 7
2006 2
2007 6
2008 5
2009 1
2010 1
2011 1
2012 5
2013 1
2014 7
2015 6
2016 12
2017 5
2018 4
2019 3
2020 7
2021 5
2022 7
2023 1
2024 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Results by year

Filters applied: . Clear all
Page 1
Molecular mechanisms of HIV latency.
Cary DC, Fujinaga K, Peterlin BM. Cary DC, et al. Among authors: fujinaga k. J Clin Invest. 2016 Feb;126(2):448-54. doi: 10.1172/JCI80565. Epub 2016 Jan 5. J Clin Invest. 2016. PMID: 26731470 Free PMC article. Review.
P-TEFb as A Promising Therapeutic Target.
Fujinaga K. Fujinaga K. Molecules. 2020 Feb 14;25(4):838. doi: 10.3390/molecules25040838. Molecules. 2020. PMID: 32075058 Free PMC article. Review.
[Adenovirus].
Fujinaga K. Fujinaga K. Tanpakushitsu Kakusan Koso. 1982;27(16):2415-9. Tanpakushitsu Kakusan Koso. 1982. PMID: 7163512 Japanese. No abstract available.
HEXIM1-Tat chimera inhibits HIV-1 replication.
Leoz M, Kukanja P, Luo Z, Huang F, Cary DC, Peterlin BM, Fujinaga K. Leoz M, et al. Among authors: fujinaga k. PLoS Pathog. 2018 Nov 5;14(11):e1007402. doi: 10.1371/journal.ppat.1007402. eCollection 2018 Nov. PLoS Pathog. 2018. PMID: 30395647 Free PMC article.
[PCR machine].
Kimura S, Fujinaga K, Sekiya T. Kimura S, et al. Among authors: fujinaga k. Tanpakushitsu Kakusan Koso. 1996 Apr;41(5):514-7. Tanpakushitsu Kakusan Koso. 1996. PMID: 8650332 Review. Japanese. No abstract available.
The two sides of Tat.
Barboric M, Fujinaga K. Barboric M, et al. Among authors: fujinaga k. Elife. 2016 Jan 19;5:e12686. doi: 10.7554/eLife.12686. Elife. 2016. PMID: 26783762 Free PMC article.
Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk.
Li Y, Liu X, Fujinaga K, Gross JD, Frankel AD. Li Y, et al. Among authors: fujinaga k. Sci Adv. 2024 Jan 19;10(3):eadi4162. doi: 10.1126/sciadv.adi4162. Epub 2024 Jan 19. Sci Adv. 2024. PMID: 38241362 Free PMC article.
DCAF1 inhibits the NF-κB pathway by targeting p65.
Huang F, Yao W, Sun B, Fujinaga K. Huang F, et al. Among authors: fujinaga k. Immunol Lett. 2022 Sep;249:33-42. doi: 10.1016/j.imlet.2022.08.005. Epub 2022 Aug 31. Immunol Lett. 2022. PMID: 36055411
319 results